相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Carbonic anhydrase inhibitors and activators for novel therapeutic applications
Claudiu T. Supuran
FUTURE MEDICINAL CHEMISTRY (2011)
Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti
Sevgi Kolayli et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2011)
Carbonic anhydrase inhibition with natural products: novel chemotypes and inhibition mechanisms
Claudiu T. Supuran
MOLECULAR DIVERSITY (2011)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?
Claudiu T. Supuran
FRONTIERS IN PHARMACOLOGY (2011)
Carbonic anhydrase inhibitors
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Brucella Carbonic Anhydrases: New Targets for Designing Anti-Infective Agents
Jean-Yves Winum et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
The beta-Carbonic Anhydrases from Mycobacterium tuberculosis as Drug Targets
Isao Nishimori et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Overview perspective of bacterial resistance
Guilherme H. Furtado et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]-thiadiazole-7-sulphonamides
Lina Baranauskiene et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2010)
Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates
Alessio Innocenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Carbonic Anhydrase Inhibitors. Cloning, Characterization, and Inhibition Studies of a New β-Carbonic Anhydrase from Mycobacterium tuberculosis
Isao Nishimori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Molecular Cloning, Characterization, and Inhibition Studies of the Rv1284 β-Carbonic Anhydrase from Mycobacterium tuberculosis with Sulfonamides and a Sulfamate
Tomoko Minakuchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of Low Nanomolar and Subnanomolar Inhibitors of the Mycobacterial β-Carbonic Anhydrases Rv1284 and Rv3273
Ozlen Guzel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structure and Inhibition of the CO2-Sensing Carbonic Anhydrase Can2 from the Pathogenic Fungus Cryptococcus neoformans
Christine Schlicker et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors
Alfonso Maresca et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis
Christopher Dye
NATURE REVIEWS MICROBIOLOGY (2009)
The alpha and beta classes carbonic Anhydrases from Helicobacter pylori as novel drug targets
Isao Nishimori et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamide
Peihua Gu et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Emerging drugs for active tuberculosis
Ann M. Ginsberg
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment
H. D. Hollis Showalter et al.
TUBERCULOSIS (2008)
Recent advances in antituberculous drug development and novel drug targets
Haruaki Tomioka et al.
Expert Review of Respiratory Medicine (2008)
Structural mechanics of the pH-dependent activity of β-carbonic anhydrase from Mycobacterium tuberculosis
AS Covarrubias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure and function of carbonic anhydrases from Mycobacterium tuberculosis
AS Covarrubias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects
S Pastorekova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2004)
Genes required for mycobacterial growth defined by high density mutagenesis
CM Sassetti et al.
MOLECULAR MICROBIOLOGY (2003)
Carbonic anhydrase inhibitors
CT Supuran et al.
MEDICINAL RESEARCH REVIEWS (2003)
Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling
JC Betts et al.
MOLECULAR MICROBIOLOGY (2002)
分享论文
